Helena Elding Larsson has been awarded a gift as support for a research project aiming to study if oral insulin given to children from 4-7 months of age to 3 years, with high genetic risk, can prevent the development of beta cell autoantibodies and later the development of type 1-diabetes.
She is one of eleven recipients who gets to share a total of 11,6 million SEK, half of which are focusing on type 1-diabetes.
The awards has been collected by the members of the Odd Fellow Orden Sverige for three years and handed out during the celebration of its 200 year jubilee.
More about the research project (link to the GPPAD homepage)
Link to the Odd Fellow Orden Sweden
